vs
Side-by-side financial comparison of MicroAlgo Inc. (MLGO) and Sol-Gel Technologies Ltd. (SLGL). Click either name above to swap in a different company.
MicroAlgo Inc. is the larger business by last-quarter revenue ($26.3M vs $17.3M, roughly 1.5× Sol-Gel Technologies Ltd.). On growth, Sol-Gel Technologies Ltd. posted the faster year-over-year revenue change (217.7% vs -35.5%).
MicroAlgo Inc. is a technology enterprise specializing in custom algorithm optimization solutions. It mainly serves clients across smart city management, industrial internet, and e-commerce sectors, helping enterprises improve operational efficiency, reduce operating costs, and optimize data processing performance for real business scenarios.
Sol-Gel Technologies Ltd. is a specialty biopharmaceutical company focused on developing and commercializing innovative dermatology treatments. Leveraging its proprietary sol-gel delivery technology, it creates topical therapies for common skin conditions including acne, rosacea and atopic dermatitis, with primary markets across North America and Europe, partnering with established healthcare firms to expand product reach.
MLGO vs SLGL — Head-to-Head
Income Statement — Q2 FY2025 vs Q2 FY2025
| Metric | | |
|---|---|---|
| Revenue | $26.3M | $17.3M |
| Net Profit | — | $11.6M |
| Gross Margin | — | — |
| Operating Margin | — | 65.1% |
| Net Margin | — | 67.3% |
| Revenue YoY | -35.5% | 217.7% |
| Net Profit YoY | — | 487.6% |
| EPS (diluted) | — | $4.17 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q2 25 | $26.3M | $17.3M | ||
| Q4 24 | $34.6M | — | ||
| Q2 24 | $40.8M | $5.4M | ||
| Q2 23 | $20.2M | $594.0K | ||
| Q1 23 | $17.8M | — | ||
| Q2 22 | $28.2M | $3.5M | ||
| Q1 22 | $23.4M | — |
| Q2 25 | — | $11.6M | ||
| Q4 24 | $4.2M | — | ||
| Q2 24 | — | $2.0M | ||
| Q2 23 | $-4.8M | $-6.0M | ||
| Q1 23 | $-1.3M | — | ||
| Q2 22 | $-23.6K | $-134.0K | ||
| Q1 22 | $888.4K | — |
| Q2 25 | — | — | ||
| Q4 24 | 26.4% | — | ||
| Q2 24 | — | — | ||
| Q2 23 | 33.0% | — | ||
| Q1 23 | 27.8% | — | ||
| Q2 22 | -0.1% | — | ||
| Q1 22 | 23.1% | — |
| Q2 25 | — | 65.1% | ||
| Q4 24 | 7.0% | — | ||
| Q2 24 | — | 29.9% | ||
| Q2 23 | -7.7% | -1098.8% | ||
| Q1 23 | -7.9% | — | ||
| Q2 22 | -0.1% | -13.2% | ||
| Q1 22 | 5.0% | — |
| Q2 25 | — | 67.3% | ||
| Q4 24 | 12.1% | — | ||
| Q2 24 | — | 36.4% | ||
| Q2 23 | -23.7% | -1005.1% | ||
| Q1 23 | -7.1% | — | ||
| Q2 22 | -0.1% | -3.8% | ||
| Q1 22 | 3.8% | — |
| Q2 25 | — | $4.17 | ||
| Q4 24 | $0.56 | — | ||
| Q2 24 | — | $0.71 | ||
| Q2 23 | — | $-0.22 | ||
| Q1 23 | — | — | ||
| Q2 22 | — | $0.01 | ||
| Q1 22 | — | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $319.4M | $24.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $317.6M | $31.9M |
| Total Assets | $330.8M | $39.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q2 25 | $319.4M | $24.3M | ||
| Q4 24 | $164.9M | — | ||
| Q2 24 | $66.7M | $26.5M | ||
| Q2 23 | $19.2M | $33.5M | ||
| Q1 23 | $21.0M | — | ||
| Q2 22 | $10.9K | $15.6M | ||
| Q1 22 | $28.7K | — |
| Q2 25 | $317.6M | $31.9M | ||
| Q4 24 | $144.9M | — | ||
| Q2 24 | $76.0M | $34.9M | ||
| Q2 23 | $60.4M | $48.3M | ||
| Q1 23 | $66.7M | — | ||
| Q2 22 | $-3.0M | $50.4M | ||
| Q1 22 | $-2.5M | — |
| Q2 25 | $330.8M | $39.3M | ||
| Q4 24 | $176.3M | — | ||
| Q2 24 | $107.6M | $42.0M | ||
| Q2 23 | $71.8M | $55.1M | ||
| Q1 23 | $75.6M | — | ||
| Q2 22 | $47.3M | $55.0M | ||
| Q1 22 | $46.8M | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
